Variations in GSTT1, GSTM1 and GSTP1 have been previously demonstrated to influence drug efficacy and toxicity and also to modify individual susceptibility to cancers [34-39] however, there are scarce data specific to patients with thyroid cancer [40-46]. The gene discussed is GSTM1; the disease is thyroid gland carcinoma.